Articles written by Santhosh Naikar - Benzinga

Ronnie Moas Downgrades Kite Pharma, Sees $100 Stock Price Through 2018

Deutsche Bank Offers Takeaways Following Meeting With FireEye CFO

Why Baidu's Margins Are Still A Concern

Whiting Petroleum's Results Were Merely 'Lackluster,' Says Iberia's Eli Kantor

4 Key Risks Goldman Sees At Twitter

Goldman Sees 'Significant' Challenges At HP

SolarCity Might Miss Guidance This Quarter, New Checks Show

BMO Thinks Valeant's Structure Is 'Questionable,' Says Investigation May Be Needed To Resolve Uncertainty

Goldman: Memorial Resource Development Has 28% Upside

1 Thing Pushing FitBit Stock Up

Cowen: In Biotech Earnings We Trust

Social Media Beat: What Experts And The Crowd Think Of Biotechs, GE And Tesla

Why IBM Needs Growth To Turn Around

Xenia Hotels: The Hottest Way To Play U.S. Lodging?

4 Different Ways To Invest In Cybersecurity

Time To Buy Micro-Cap CymaBay Therapeutics: H.C. Wainwright

How ETFs Work & Why They Differ From Mutual Funds

An Underrated Cost Savings King With A 2016 Outlook

Campbell Soup: A Return To Growth In 2016

Can Schlumberger Outperform The Market? Citi Thinks So